Back to Journals » Drug Design, Development and Therapy » Volume 15

A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy

Total article views   HTML views PDF downloads Totals
4,874 Dovepress* 4,449+ 217 4,666
PubMed Central* 425 198 623
Totals 4,874 415 5,289
*Since 16 November 2021

View citations on PubMed Central and Google Scholar